Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 5th edition, 486 pages

Free download

  Colorectal Neoplasms

  Free Subscription


1 Adv Exp Med Biol
1 Am J Epidemiol
1 Am J Surg
4 Ann Surg Oncol
3 BMC Cancer
1 Br J Cancer
3 Clin Cancer Res
1 Dig Dis
5 Dis Colon Rectum
3 Eur J Surg Oncol
3 Gastroenterology
2 Int J Cancer
2 Int J Colorectal Dis
1 Int J Oncol
1 Lancet Oncol
1 Oncogene
4 Oncol Rep
1 Oncology (Williston Park)
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Adv Exp Med Biol

  1. KIM H, Giovannucci E
    Vitamin D Status and Cancer Incidence, Survival, and Mortality.
    Adv Exp Med Biol. 2020;1268:39-52.
    PubMed         Abstract available

    Am J Epidemiol

  2. DOLLADILLE C, Launoy G, Bouvier V, Salem JE, et al
    Anticancer drugs and cardiovascular-related hospitalization in metastatic colorectal cancer: Insights from the AVOCETTE population-based study.
    Am J Epidemiol. 2020 Sep 23. pii: 5910083. doi: 10.1093.
    PubMed         Abstract available

    Am J Surg

  3. VU JV, Morris AM, Maguire LH, De Roo AC, et al
    Development and characteristics of a multidisciplinary colorectal cancer clinic.
    Am J Surg. 2020 Aug 27. pii: S0002-9610(20)30522.
    PubMed         Abstract available

    Ann Surg Oncol

  4. CREASY JM, Cunanan KM, Chakraborty J, McAuliffe JC, et al
    Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon Cancer.
    Ann Surg Oncol. 2020 Sep 20. pii: 10.1245/s10434-020-09134.
    PubMed         Abstract available

  5. ADILEH M, Mor E, Assaf D, Benvenisti H, et al
    Perioperative and Oncological Outcomes of Combined Hepatectomy with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2020 Sep 23. pii: 10.1245/s10434-020-09165.
    PubMed         Abstract available

  6. MARGONIS GA, Andreatos N, Kreis ME, D'Angelica M, et al
    The Interplay of Primary Tumor Location and KRAS Mutation Status in Patients with Synchronous Colorectal Cancer Liver Metastases: Current Data and Unanswered Questions.
    Ann Surg Oncol. 2020 Sep 21. pii: 10.1245/s10434-020-09144.

  7. KLOSE J, Kloor M, Warschkow R, Antony P, et al
    Does Side Really Matter? Survival Analysis among Patients with Right- Versus Left-Sided Colon Cancer: A Propensity Score-Adjusted Analysis.
    Ann Surg Oncol. 2020 Sep 21. pii: 10.1245/s10434-020-09116.
    PubMed         Abstract available

    BMC Cancer

  8. LICHTHARDT S, Wagner J, Lob S, Matthes N, et al
    Pathological complete response due to a prolonged time interval between preoperative chemoradiation and surgery in locally advanced rectal cancer: analysis from the German StuDoQ|Rectalcarcinoma registry.
    BMC Cancer. 2020;20:49.
    PubMed         Abstract available

  9. ARIANS N, Hafner M, Krisam J, Lang K, et al
    Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) - a prospective, randomized, 2-armed phase-II-trial.
    BMC Cancer. 2020;20:52.
    PubMed         Abstract available

  10. CHEN H, Luo J, Guo J
    Identification of an alternative splicing signature as an independent factor in colon cancer.
    BMC Cancer. 2020;20:904.
    PubMed         Abstract available

    Br J Cancer

  11. SIMIN J, Fornes R, Liu Q, Olsen RS, et al
    Antibiotic use and risk of colorectal cancer: a systematic review and dose-response meta-analysis.
    Br J Cancer. 2020 Sep 24. pii: 10.1038/s41416-020-01082.
    PubMed         Abstract available

    Clin Cancer Res

  12. NUSRAT M
    Response to anti-PD-1 in microsatellite stable colorectal cancer: a STAT need.
    Clin Cancer Res. 2020 Sep 21. pii: 1078-0432.CCR-20-2901.
    PubMed         Abstract available

  13. INNOCENTI F, Sibley AB, Patil SA, Etheridge AS, et al
    Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance).
    Clin Cancer Res. 2020 Sep 21. pii: 1078-0432.CCR-20-2021.
    PubMed         Abstract available

  14. STAHLER A, Stintzing S, Modest DP, Ricard I, et al
    Amphiregulin expression is a predictive biomarker for EGFR inhibition in metastatic colorectal cancer: combined analysis of three randomized trials.
    Clin Cancer Res. 2020 Sep 17. pii: 1078-0432.CCR-20-2748.
    PubMed         Abstract available

    Dig Dis

  15. BARABAS L, Hritz I, Istvan G, Tulassay Z, et al
    The behavior of MMP-2, MMP-7, MMP-9 and their inhibitors TIMP-1, TIMP-2 in adenoma-colorectal cancer sequence.
    Dig Dis. 2020 Sep 22. pii: 000511765. doi: 10.1159/000511765.
    PubMed         Abstract available

    Dis Colon Rectum

  16. DEGIULI M, Reddavid R, Ricceri F, Di Candido F, et al
    Segmental Colonic Resection Is a Safe and Effective Treatment Option for Colon Cancer of the Splenic Flexure: A Nationwide Retrospective Study of the Italian Society of Surgical Oncology-Colorectal Cancer Network Collaborative Group.
    Dis Colon Rectum. 2020;63:1372-1382.
    PubMed         Abstract available

  17. CHEN PJ, Li TL, Sun TT, Willis VC, et al
    Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival.
    Dis Colon Rectum. 2020;63:1383-1392.
    PubMed         Abstract available

  18. OFSHTEYN A, Jiang B, Bingmer K, Nakayama JM, et al
    Prophylactic Gynecologic Surgery at Time of Colectomy Benefits Women with Lynch Syndrome and Colon Cancer: A Markov Cost-Effectiveness Analysis.
    Dis Colon Rectum. 2020;63:1393-1402.
    PubMed         Abstract available

  19. WOO IT, Park JS, Kang BW, Park SY, et al
    Impact of Anatomic Extent of Nodal Metastasis on Adjuvant Chemotherapy Outcomes in Stage III Colon Cancer.
    Dis Colon Rectum. 2020;63:1455-1465.
    PubMed         Abstract available

  20. BAIK H, Bae KB
    Robotic Complete Mesocolic Excision After Neoadjuvant Chemotherapy for Advanced Ascending Colon Cancer.
    Dis Colon Rectum. 2020;63:1474.

    Eur J Surg Oncol

  21. EL-SHARKAWY F, Gushchin V, Plerhoples TA, Liu C, et al
    Minimally invasive surgery for T4 colon cancer is associated with better outcomes compared to open surgery in the National Cancer Database.
    Eur J Surg Oncol. 2020 Sep 10. pii: S0748-7983(20)30725.
    PubMed         Abstract available

  22. LO DICO R, Faron M, Yonemura Y, Glehen O, et al
    Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI).
    Eur J Surg Oncol. 2020 Aug 26. pii: S0748-7983(20)30666.

  23. OW ZGW, Sim W, Nistala KRY, Ng CH, et al
    Comparing complete mesocolic excision versus conventional colectomy for colon cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2020 Sep 12. pii: S0748-7983(20)30778.
    PubMed         Abstract available


  24. DEKKER E, Chiu HM, Lansdorp-Vogelaar I, Caro LE, et al
    Colorectal cancer screening in the COVID-19 era.
    Gastroenterology. 2020 Sep 20. pii: S0016-5085(20)35169.

  25. JUN SY, Brown AJ, Chua NK, Yoon JY, et al
    Reduction of squalene epoxidase by cholesterol accumulation accelerates colorectal cancer progression and metastasis.
    Gastroenterology. 2020 Sep 15. pii: S0016-5085(20)35146.
    PubMed         Abstract available

  26. LUI TKL, Leung K, Guo CG, Tsui VWM, et al
    Impacts of the Coronavirus 2019 Pandemic on Gastrointestinal Endoscopy Volume and Diagnosis of Gastric and Colorectal Cancers: A Population-Based Study.
    Gastroenterology. 2020;159:1164-1166.

    Int J Cancer

  27. UNSELD M, Belic J, Pierer K, Zhou Q, et al
    A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy (RELAIS) translational biomarker phase II pilot study.
    Int J Cancer. 2020 Sep 19. doi: 10.1002/ijc.33303.
    PubMed         Abstract available

  28. HWANG JH, Yoon J, Cho YH, Cha PH, et al
    A mutant KRAS-induced factor REG4 promotes cancer stem cell properties via Wnt/beta-catenin signaling.
    Int J Cancer. 2020;146:2877-2890.
    PubMed         Abstract available

    Int J Colorectal Dis

  29. LEE JW, Choi EA, Kim YS, Kim Y, et al
    Metformin usage and the risk of colorectal cancer: a national cohort study.
    Int J Colorectal Dis. 2020 Sep 23. pii: 10.1007/s00384-020-03765.
    PubMed         Abstract available

  30. TANG M, Wang H, Cao Y, Zeng Z, et al
    Nomogram for predicting occurrence and prognosis of liver metastasis in colorectal cancer: a population-based study.
    Int J Colorectal Dis. 2020 Sep 23. pii: 10.1007/s00384-020-03722.
    PubMed         Abstract available

    Int J Oncol

  31. KIM SL, La MT, Shin MW, Kim SW, et al
    A novel HDAC1 inhibitor, CBUD1001, exerts anticancer effects by modulating the apoptosis and EMT of colorectal cancer cells.
    Int J Oncol. 2020 Aug 10. doi: 10.3892/ijo.2020.5109.
    PubMed         Abstract available

    Lancet Oncol

  32. GOERE D, Glehen O, Quenet F, Guilloit JM, et al
    Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.
    Lancet Oncol. 2020;21:1147-1154.
    PubMed         Abstract available


  33. JIN G, Yan M, Liu K, Yao K, et al
    Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer.
    Oncogene. 2020 Sep 22. pii: 10.1038/s41388-020-01467.
    PubMed         Abstract available

    Oncol Rep

  34. LIANG Y, Lv Z, Huang G, Qin J, et al
    Prognostic significance of abnormal matrix collagen remodeling in colorectal cancer based on histologic and bioinformatics analysis.
    Oncol Rep. 2020 Aug 11. doi: 10.3892/or.2020.7729.
    PubMed         Abstract available

  35. HONG S, Cai W, Huang Z, Wang Y, et al
    Ginsenoside Rg3 enhances the anticancer effect of 5FU in colon cancer cells via the PI3K/AKT pathway.
    Oncol Rep. 2020 Aug 11. doi: 10.3892/or.2020.7728.
    PubMed         Abstract available

  36. PEREZ AG, Andrade-Da-Costa J, De Souza WF, De Souza Ferreira M, et al
    Nglycosylation and receptor tyrosine kinase signaling affect claudin3 levels in colorectal cancer cells.
    Oncol Rep. 2020 Aug 11. doi: 10.3892/or.2020.7727.
    PubMed         Abstract available

  37. SUN Y, Liu Y, Cai Y, Han P, et al
    Downregulation of LINC00958 inhibits proliferation, invasion and migration, and promotes apoptosis of colorectal cancer cells by targeting miR36195p.
    Oncol Rep. 2020 Jul 29. doi: 10.3892/or.2020.7707.
    PubMed         Abstract available

    Oncology (Williston Park)

  38. ARMSTRONG SA, Malley R, Weinberg BA
    Molecular Profiling in Metastatic Colorectal Cancer.
    Oncology (Williston Park). 2020;34:352-355.
    PubMed         Abstract available

    PLoS One

  39. MIYAMOTO Y, Schirripa M, Suenaga M, Cao S, et al
    A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer.
    PLoS One. 2020;15:e0239439.
    PubMed         Abstract available

  40. HILSDEN RJ, Maxwell CM, Forbes N, Bridges RJ, et al
    Development of a definition and rules for causal attribution of post-colonoscopy bleeding.
    PLoS One. 2020;15:e0235902.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.